首页> 外文期刊>Plant Biotechnology Journal >Optimization of the expression of the HIV fusion inhibitor cyanovirin-N from the tobacco plastid genome
【24h】

Optimization of the expression of the HIV fusion inhibitor cyanovirin-N from the tobacco plastid genome

机译:从烟草塑性基因组中优化HIV融合抑制剂氰化素-N的表达

获取原文
获取原文并翻译 | 示例
       

摘要

P>Plants with transgenic plastid (chloroplast) genomes represent a promising production platform in molecular farming, mainly because of the plastids' potential to accumulate foreign proteins to very high levels and the increased biosafety conferred by the maternal mode of plastid inheritance. Although some transgenes can be expressed to extraordinarily high levels, the expression of others has been unsuccessful. Lack of detectable transgene expression is usually attributable to either RNA instability or protein instability. Here, we have investigated the possibilities to improve the production of a pharmaceutical protein that is difficult to express in chloroplasts: the HIV-1 fusion inhibitor cyanovirin-N (CV-N). Testing various N-terminal and C-terminal fusions to peptide sequences from two proteins known to accumulate to high levels in transgenic plastids (GFP and the protein antibiotic PlyGBS), we show that both low mRNA stability and low protein stability contribute to the lack of detectable CV-N expression in chloroplasts. Both problems can be alleviated by N-terminal fusions to the CV-N coding region, thus highlighting a suitable strategy for optimization of plastid transgene expression.
机译:p>具有转基因塑性(叶绿体)基因组的植物代表了分子养殖的有前景的生产平台,主要是因为塑性潜力积聚到非常高的水平,并且通过母体遗传赋予母体模式赋予的生物安全增加。虽然一些转基因可以表达出色,但他人的表达一直不成功。缺乏可检测的转基因表达通常归因于RNA不稳定性或蛋白质不稳定性。在这里,我们研究了改善难以在叶绿体中表达的药物蛋白质的产生的可能性:HIV-1融合抑制剂Cyanovirin-N(CV-N)。从已知的两种蛋白质中测试各种N末端和C末端融合到从转基因体积(GFP和蛋白质抗生素粒子)中的两种蛋白质中,我们表明,低mRNA稳定性和低蛋白质稳定性有助于缺乏可检测叶绿体中的CV-N表达。对于CV-N编码区域的N末端融合可以减轻两个问题,从而突出了优化体层转基因表达的合适策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号